SKAN Stock Overview
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
SKAN Group AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 73.20 |
| 52 Week High | CHF 86.60 |
| 52 Week Low | CHF 69.40 |
| Beta | 0.95 |
| 11 Month Change | -7.92% |
| 3 Month Change | -8.61% |
| 1 Year Change | -9.07% |
| 33 Year Change | -17.78% |
| 5 Year Change | 695.65% |
| Change since IPO | 960.87% |
Recent News & Updates
SKAN Group (VTX:SKAN) Has A Pretty Healthy Balance Sheet
Nov 09
Should You Investigate SKAN Group AG (VTX:SKAN) At CHF77.10?
Oct 08Recent updates
SKAN Group (VTX:SKAN) Has A Pretty Healthy Balance Sheet
Nov 09Should You Investigate SKAN Group AG (VTX:SKAN) At CHF77.10?
Oct 08A Look At The Intrinsic Value Of SKAN Group AG (VTX:SKAN)
Jul 27Is SKAN Group AG (VTX:SKAN) Potentially Undervalued?
Jun 19SKAN Group AG's (VTX:SKAN) P/E Is On The Mark
May 30Do SKAN Group's (VTX:SKAN) Earnings Warrant Your Attention?
May 14We Take A Look At Why SKAN Group AG's (VTX:SKAN) CEO Has Earned Their Pay Packet
May 01Is There An Opportunity With SKAN Group AG's (VTX:SKAN) 27% Undervaluation?
Apr 19We Think That There Are Issues Underlying SKAN Group's (VTX:SKAN) Earnings
Apr 03SKAN Group AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 29When Should You Buy SKAN Group AG (VTX:SKAN)?
Mar 11SKAN Group AG's (VTX:SKAN) Earnings Haven't Escaped The Attention Of Investors
Jan 26Estimating The Fair Value Of SKAN Group AG (VTX:SKAN)
Dec 21Is There Now An Opportunity In SKAN Group AG (VTX:SKAN)?
Nov 22A Look At The Fair Value Of SKAN Group AG (VTX:SKAN)
Sep 21How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Mar 11Here's Why I Think BV Holding (BRN:BVHN) Is An Interesting Stock
Feb 04
Did You Participate In Any Of BV Holding's (BRN:BVHN) Fantastic 204% Return ?
Dec 31How Much Of BV Holding AG (BRN:BVHN) Do Insiders Own?
Dec 03Shareholder Returns
| SKAN | CH Life Sciences | CH Market | |
|---|---|---|---|
| 7D | -7.1% | -6.9% | -1.4% |
| 1Y | -9.1% | 28.9% | 4.8% |
Return vs Industry: SKAN underperformed the Swiss Life Sciences industry which returned 28.3% over the past year.
Return vs Market: SKAN underperformed the Swiss Market which returned 5.2% over the past year.
Price Volatility
| SKAN volatility | |
|---|---|
| SKAN Average Weekly Movement | 3.4% |
| Life Sciences Industry Average Movement | 4.0% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in CH Market | 6.5% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: SKAN has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: SKAN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,419 | GL Huber | skan.com/de/home/ |
SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Asia, Europe, the Americas, and internationally. It operates in two segments: Equipment and Solutions and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.
SKAN Group AG Fundamentals Summary
| SKAN fundamental statistics | |
|---|---|
| Market cap | CHF 1.65b |
| Earnings (TTM) | CHF 32.24m |
| Revenue (TTM) | CHF 344.01m |
51.1x
P/E Ratio4.8x
P/S RatioIs SKAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SKAN income statement (TTM) | |
|---|---|
| Revenue | CHF 344.01m |
| Cost of Revenue | CHF 95.69m |
| Gross Profit | CHF 248.32m |
| Other Expenses | CHF 216.08m |
| Earnings | CHF 32.24m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 25, 2025
| Earnings per share (EPS) | 1.43 |
| Gross Margin | 72.18% |
| Net Profit Margin | 9.37% |
| Debt/Equity Ratio | 3.5% |
How did SKAN perform over the long term?
See historical performance and comparison